Press Releases
Cenduit LLC to Present Webinar Case Study on How to Help Biopharma Sponsors and CROs Navigate IRT System Change Requests (SCRs)
DURHAM, NC, UNITED STATES - Nov 27, 2018 - On Wednesday, December 12, Cenduit subject matter experts Andrew Rohrbaugh, Director of Client Delivery; and Chris Gent, Associate Director of Operational Excellence, will present a case study, in a free educational webinar on how sponsors and CROs can successfully steer through the rising tide of Protocol Amendments and System Change Requests (SCRs) utilizing a patient centric approach. Attendees will learn about recent examples that demonstrate how to maintain high quality, while reducing overall lead time, and to take IRT system updates off the critical path. If mismanaged, SCRs can delay a study for months, or even end it. Cenduits team of experts will help attendees learn to better navigate these risks, via a rapid-fire learning session.
- Date: Wednesday, December 12, 2018 - 45 minutes
- Time: 7am PDT | 10am EDT | 3pm BST |4pm CEST
- Cenduit Presenters: Andrew Rohrbaugh, Director of Client Delivery; and Chris Gent, Associate Director of Operational Excellence
- Register Here
Attendees will:
- Hear an academic review on the impact of protocol amendments in clinical studies
- Learn how an agile, configurable approach can reduce timelines, keeping patient benefit at the forefront of your study
- Understand how to apply an Operational Excellence (OpEx) approach to IRT system changes
Join us for this interactive session on an important emerging trend in the eClinical trials and biopharma industry. Register Here
About the Presenters
Andrew Rohrbaugh, Director of Client Delivery - Rohrbaugh has 10+ years of clinical trial industry experience including project and account management of IRT, eSource, eCOA and Connected Devices. He has extensive experience in implementing enterprise level solutions focused on standardization within unique customer needs. He has served as a past presenter at numerous eClinical solutions events and webcasts with organizations including IRT USA and industry publications.
Christopher Gent, Associate Director of Operational & Process Excellence - Gent has 18+ years of experience in software delivery, quality assurance, computer system validation and operational excellence in drug development. He drives resource optimization, productivity and process improvement initiatives for optimizing Cenduit's organizational capabilities. Gent is an expert in LEAN transformation initiatives in digital health and eClinical technology for improved client and patient experience. Clickhereto read Christopher Gents informative blog on how Cenduit helps clients successfully address SCRs.
SCRs are a fact of life. Register today to learn how your organization can leverage innovative technology and processes to deploy customizable, configurable studies with the quality built in to handle SCRs quickly, while maintaining data integrity and patient safety.
About Cenduit LLC
Cenduit enables clinical study sponsors and CROs to safely, quickly and economically deliver new drugs and therapies that improve and save lives. As the world leader in quality IRT systems, Cenduit accelerates study startup, with clinical supply chain intelligence, deep clinical operations expertise and client-centric CORE teams. With 500+ experts throughout the US, Europe and Asia, Cenduit helps customers manage clinical studies in over 100 countries, interacting with nearly 1,000,000 patients at over 32,000 sites. Visit www.cenduit.com for more information.
Contact:
Shannon L. Davies, Shannon.lappindavies@cenduit.com, +1 919-998-3393
Brenda Nashawaty, brenda@nashawaty.com, +1 617-688-3253
